A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Crohn's Disease
Conditions: Crohn Disease; IBS - Irritable Bowel Syndrome Intervention: Drug: Bone Marrow MSC Derived Extracellular Vesicle Isolate Sponsor: Direct Biologics, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Crohn's Disease | Inflammatory Bowel Disease | Research | Stem Cell Therapy | Stem Cells | Study